Related Experiment Video

Updated: May 15, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Decreased RB1 mRNA, protein, and activity reflect obesity-induced altered adipogenic capacity in human adipose tissue

José María Moreno-Navarrete1, Petar Petrov, Marta Serrano

  • 1Service of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona and CIBER Fisiopatología de la Obesidad y Nutrición CB06/03/010, Girona, Spain.

Diabetes
|January 15, 2013
PubMed

Insights

Retinoblastoma protein 1 (RB1) is crucial for human fat cell function. Its levels decrease with obesity and increase during fat cell differentiation, suggesting a key role in metabolic health.

Area of Science:

  • Metabolic research
  • Adipose tissue biology
  • Obesity research

Background:

  • Retinoblastoma protein 1 (RB1) is known to be essential for white adipocyte differentiation in mice.
  • Previous research has not investigated the role of RB1 in human adipose tissue or adipocytes.

Purpose of the Study:

  • To investigate the role and regulation of RB1 in human adipose tissue during obesity.
  • To explore RB1's function in adipocyte differentiation and maintenance using human and animal models.

Main Methods:

  • Analysis of RB1 (mRNA, protein, activity) in human visceral and subcutaneous adipose tissue.
  • Investigation of RB1 in diet-induced obesity in rats.
  • Study of RB1 expression during human adipocyte differentiation in vitro.
  • RB1 knockdown experiments in differentiated human adipocytes.

Main Results:

  • Adipose RB1 levels negatively correlated with BMI and insulin resistance (HOMA-IR) in humans.
  • Increased BMI was the primary factor in adipose RB1 downregulation.
  • RB1 expression and activity decreased with weight gain in rats and normalized with weight loss.
  • RB1 expression and activity increased during human adipocyte differentiation.
  • RB1 knockdown in differentiated adipocytes resulted in loss of adipogenic phenotype.

Conclusions:

  • RB1 plays a permissive role in human adipose tissue function.
  • RB1 is downregulated in obesity and upregulated during adipocyte differentiation.
  • RB1 is necessary for maintaining the characteristics of fully differentiated human adipocytes.

More Related Videos

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator06:08

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...